Prostate Cancer - Results from #22580

Biological dose escalation and hypofractionation: What is there to be gained and how will it best be done? - Abstract August 12, 2013

Molecular classification of prostate cancer progression: Foundation for marker-driven treatment of prostate cancer - Abstract August 12, 2013

Follow-up for clinically localized renal neoplasms: AUA Guideline - Abstract August 9, 2013

Skeletal-related events among breast and prostate cancer patients: Towards new treatment initiation in Malaysia's hospital setting - Abstract August 9, 2013

Molecular diagnosis of prostate cancer: Are we up to age? - Abstract August 9, 2013

The dilemma of a rising prostate-specific antigen level after local therapy: What are our options? - Abstract August 9, 2013

Monitoring the clinical outcomes in advanced prostate cancer: What imaging modalities and other markers are reliable? - Abstract August 9, 2013

Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer - Abstract August 9, 2013

Laparoscopic versus robot-assisted bilateral nerve-sparing radical prostatectomy: Comparison of pentafecta rates for a single surgeon - Abstract August 9, 2013

Prostate cancer in Luxembourg from 1982 to 2006. Incidence and mortality. Survival of a hospital cohort - Abstract August 9, 2013

Clinical implications of current developments in genitourinary pathology - Abstract August 9, 2013

Targeting epigenetics for the treatment of prostate cancer: Recent progress and future directions - Abstract August 9, 2013

Novel approaches for the identification of biomarkers of aggressive prostate cancer - Abstract August 9, 2013

Barriers to prostate cancer prevention and community recommended health education strategies in an urban African American community in Jackson, Mississippi - Abstract August 8, 2013

Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group - Abstract August 8, 2013

Molecular pathogenesis and progression of prostate cancer - Abstract August 8, 2013

Prostate cancer chemoprevention - Abstract August 8, 2013

Pushing the limits of radiation therapy for prostate cancer: Where do we go next? - Abstract August 8, 2013

Multimodality therapy for patients with high-risk prostate cancer: Current status and future directions - Abstract August 8, 2013

Non-castrate metastatic prostate cancer: Have the treatment options changed? - Abstract August 8, 2013

Page 1130 of 1437